ASOs, CBOs and Pharmacists: Untapped Partnerships for Success
Resource updated 08/28/2023
Resource updated 08/28/2023
Series of webinars for Ryan White HIV/AIDS Program (RWHAP) agencies, by HRSA's HIV/AIDS Bureau.
Resource updated 03/07/2024
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
In response to clinic operation curtailments during COVID-19 lockdowns, telehealth services have expanded across the nation.
Blog updated 01/17/2023
CDC issued an April 28, 2020 Dear Colleague HIV Self Testing Guidance, which encourages agencies to provide clients with self-test kits approved by FDA, along with linkages to HIV care for those testing positive.
Resource updated 10/26/2021
Blog updated 02/01/2021
Resource updated 09/19/2023
Resource updated 05/18/2021
Resource updated 03/15/2023
Three case studies about success strategies needed for different regional recipients: the Iowa Department of Public Health and the Part A programs of Dallas, Texas, and Paterson, N.J. Each program will detail how it used an online evidenced-based approach to improve its response to the epidemic.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Learn about strategies for improving access to oral healthcare through better integration with primary care. Presenters will share information on the seven components of integration, ranging from risk assessments to data sharing across settings. This session will introduce the components of integration and highlight available resources for integrative care.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review how the Michigan Department of Health and Human Services Chronic Disease Division collaborated with the HIV/STI division and local AIDS service organizations to develop innovative, client-centered tobacco dependence treatment programs to address the high tobacco use rates among people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Presentation of a mixed-methods needs assessment to inform a multi-site evaluation plan for a HRSA Special Projects of National Significance (SPNS) project to improve bacterial STI screening, testing, and treatment among people with or at risk for HIV will be presented, including findings, selected evidence-based interventions, and a proposed multi-site evaluation plan.
Resource (Conference Presentation) updated 09/14/2023
Cuaderno de trabajo sobre cómo establecer y operar una junta asesora para los consumidores (CAB, siglas en inglés), relacionada con las operaciones de CAB para los programas dirigidos a las mujeres, bebés, niños y jóvenes de la Parte D (Título IV).
Resource updated 09/19/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023